Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,625 | 38 | 45.7% |
| Consulting Fee | $41,906 | 22 | 28.3% |
| Travel and Lodging | $18,195 | 60 | 12.3% |
| Food and Beverage | $13,369 | 428 | 9.0% |
| Current or prospective ownership or investment interest | $5,891 | 2 | 4.0% |
| Education | $643.95 | 9 | 0.4% |
| Gift | $155.20 | 1 | 0.1% |
| Entertainment | $120.46 | 1 | 0.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avadel Specialty Pharmaceuticals, LLC | $69,894 | 80 | $0 (2018) |
| Allergan, Inc. | $44,060 | 75 | $0 (2021) |
| NxThera, Inc. | $15,910 | 21 | $0 (2017) |
| Innovative Medical Technologies, LLC | $5,891 | 7 | $0 (2021) |
| Astellas Pharma US Inc | $2,454 | 96 | $0 (2024) |
| Progenics Pharmaceuticals, Inc. | $1,386 | 3 | $0 (2023) |
| Boston Scientific Corporation | $898.15 | 19 | $0 (2024) |
| Medtronic USA, Inc. | $657.38 | 9 | $0 (2018) |
| Myriad Genetic Laboratories, Inc. | $625.02 | 21 | $0 (2024) |
| NeoTract Inc. | $458.85 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,243 | 46 | Olympus America Inc. ($290.17) |
| 2023 | $1,332 | 46 | Myriad Genetic Laboratories, Inc. ($324.81) |
| 2022 | $1,097 | 45 | Boston Scientific Corporation ($172.00) |
| 2021 | $9,530 | 71 | Allergan, Inc. ($8,343) |
| 2020 | $5,994 | 34 | Allergan, Inc. ($4,053) |
| 2019 | $6,695 | 73 | Allergan Inc. ($4,672) |
| 2018 | $76,095 | 144 | Avadel Specialty Pharmaceuticals, LLC ($69,894) |
| 2017 | $45,920 | 107 | Allergan Inc. ($22,862) |
All Payment Transactions
566 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/03/2024 | Ferring Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $25.98 | General |
| 12/02/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $62.15 | General |
| Category: Urology Gynecology | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Urology | ||||||
| 11/05/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $34.61 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: HORMONE THERAPY | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $43.50 | General |
| Category: Urology Gynecology | ||||||
| 07/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/16/2024 | KARL STORZ Endoscopy-America | HOPKINS (Device) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: LAPAROSCOPY | ||||||
| 07/11/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $33.67 | General |
| Category: UROLOGY | ||||||
| 07/09/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: Urology Gynecology | ||||||
| 06/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/10/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $35.42 | General |
| Category: Urology Gynecology | ||||||
| 05/30/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Urology Gynecology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,779 | 4,750 | $754,069 | $168,439 |
| 2022 | 25 | 1,725 | 4,518 | $908,328 | $176,948 |
| 2021 | 20 | 1,310 | 3,993 | $609,683 | $129,110 |
| 2020 | 15 | 655 | 754 | $233,323 | $46,407 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 320 | $63,360 | $28,802 | 45.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 188 | $129,047 | $25,386 | 19.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 123 | 135 | $91,125 | $22,297 | 24.5% |
| 52649 | Complete laser fragmentation of prostate including control of bleeding using an endoscope | Facility | 2023 | 25 | 25 | $52,475 | $16,150 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 231 | $31,185 | $15,176 | 48.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 13 | 2,200 | $44,000 | $10,941 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $22,950 | $8,840 | 38.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 92 | 92 | $18,584 | $7,012 | 37.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 16 | 16 | $19,516 | $5,025 | 25.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 13 | 16 | $13,984 | $4,554 | 32.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 366 | 539 | $152,537 | $4,054 | 2.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 15 | $12,075 | $3,706 | 30.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 24 | $6,168 | $2,356 | 38.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 21 | $37,325 | $2,018 | 5.4% |
| 51040 | Incision of bladder with drainage | Facility | 2023 | 11 | 11 | $8,019 | $2,003 | 25.0% |
| 51705 | Simple change of bladder tube | Office | 2023 | 12 | 28 | $3,724 | $1,954 | 52.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 11 | 11 | $5,742 | $1,895 | 33.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 404 | 675 | $10,800 | $1,481 | 13.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 20 | 22 | $4,004 | $1,293 | 32.3% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Facility | 2023 | 11 | 11 | $3,575 | $1,101 | 30.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 22 | 32 | $5,600 | $822.40 | 14.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 16 | $2,368 | $705.39 | 29.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 12 | 12 | $3,396 | $380.76 | 11.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 11 | 11 | $6,930 | $267.52 | 3.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2023 | 12 | 12 | $3,504 | $177.12 | 5.1% |
About Dr. Michael Gambla, M.D
Dr. Michael Gambla, M.D is a Urology healthcare provider based in Worthington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952367641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gambla, M.D has received a total of $147,906 in payments from pharmaceutical and medical device companies, with $1,243 received in 2024. These payments were reported across 566 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,625).
As a Medicare-enrolled provider, Gambla has provided services to 5,469 Medicare beneficiaries, totaling 14,015 services with total Medicare billing of $520,904. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Worthington, OH
- Active Since 04/22/2006
- Last Updated 02/13/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1952367641
Products in Payments
- Noctiva (Drug) $69,894
- BOTOX (Biological) $29,732
- Rezum (Device) $15,910
- BOTOX (Drug) $4,636
- BOTOX OAB (Drug) $3,313
- BOTOX THERAPEUTIC - HH (Biological) $3,128
- BOTOX UROLOGY (Drug) $800.00
- Myrbetriq (Drug) $686.14
- MYRBETRIQ (Drug) $614.42
- XTANDI (Drug) $460.94
- PROVENGE (Drug) $428.10
- INTERSTIM (Device) $377.14
- ORGOVYX (Drug) $359.40
- PROLARIS (Device) $358.60
- iTIND System (Device) $340.58
- JELMYTO (Drug) $336.26
- GEMTESA (Drug) $331.94
- UroLift (Device) $327.85
- ENTERRA (Device) $306.00
- LithoVue (Device) $270.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Worthington
Dr. Ronney Abaza, M.d, M.D
Urology — Payments: $494,209
Dr. William Bloch, M.d, M.D
Urology — Payments: $13,940
Dr. Michael Cunningham, M.d, M.D
Urology — Payments: $11,617
Dr. Matthew Riebel, M.d, M.D
Urology — Payments: $8,836
Colin Ryan, M.d, M.D
Urology — Payments: $8,477
Jonathan Corbett, Md, MD
Urology — Payments: $3,812